Why the study?
Large-bore mechanical thrombectomy is an emerging treatment for high-risk and intermediate-high-risk PE, especially in patients with contraindications to thrombolysis, but safety and clinical outcomes warranted evaluation in this setting.
Does large-bore mechanical thrombectomy improve hemodynamics and clinical outcomes in patients with acute pulmonary embolism?
Comparison
Large-bore mechanical thrombectomy using the FlowTriever system (single-arm)
Design
Bi-centre retrospective cohort study
Follow-up
30 days
Key result
Large-bore mechanical thrombectomy using the FlowTriever system decreased mean pulmonary artery pressure by 27% (p<0.0001) with a 5% rate of major complications and 5% 30-day mortality.
Authors
Loading...
LBMT with FlowTriever appears feasible in acute PE; leaves open comparative efficacy versus thrombolysis or anticoagulation in randomized trials.
Cohort (n=60)
Yes
Does large-bore mechanical thrombectomy improve hemodynamics and clinical outcomes in patients with acute pulmonary embolism?
p-value: p=<0.0001
Large-bore mechanical thrombectomy with the FlowTriever system provides rapid hemodynamic improvement and high technical success in selected patients with acute pulmonary embolism.
Selleslag et al. (2026) conducted a cohort in acute pulmonary embolism (n=60). Large-bore mechanical thrombectomy (FlowTriever) was evaluated on reduction in mean pulmonary artery pressure (mPAP) (p=<0.0001). Large-bore mechanical thrombectomy using the FlowTriever system decreased mean pulmonary artery pressure by 27% (p<0.0001) with a 5% rate of major complications and 5% 30-day mortality.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: